C3d-binding assay for the detection of complement activating HLA antibodies: A useful tool for allocation to highly sensitised recipients in the post-CDC era?
Sign Up to like & getrecommendations! Published in 2023 at "HLA"
DOI: 10.1111/tan.15010
Abstract: INTRODUCTION The CDC crossmatch test is being phased out in solid organ donor allocation, and standard luminex single antigen bead assays do not differentiate complement activating function of HLA antibodies. The current study investigated the… read more here.
Keywords: hla antibodies; highly sensitised; complement activating; cdc ... See more keywords